Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny veggies, big promise? study tests MicroVeg against inflammation

NCT ID NCT06384690

Disease control Sponsor: University of Exeter Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily freeze-dried micro-vegetable blend can reduce inflammation in adults aged 60 and older with a BMI over 25. Thirty-two participants took the supplement or a placebo for six weeks. Researchers measured changes in proteins and inflammatory markers in the blood, as well as effects on cognition and gut bacteria.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
freeze-dried micro-vegetable blend
What this could lead to
If it works, this could point toward a simple dietary supplement to help control inflammation in older adults.
What could go wrong
This is a small, early-stage study with only 32 participants. Results may not apply to everyone, and the supplement might not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Feb 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 60 years and above * Body mass index \> 25kg/m2 * Able to give written informed consent to participate in the study Exclusion Criteria: * Not meeting any inclusion criteria * Have had an adverse reaction to a local anaesthetic in the past * Hepatitis B, Hepatitis C or HIV positive * Have a bleeding disorder or are regularly taking a medication that will impair their blood's capacity to clot (e.g., aspirin, clopidogrel, warfarin, heparin) * Have had a severe adverse reaction to plasters * Have a gastrointestinal disorder that may impair the absorption of the supplement from the gastrointestinal tract * Have an autoimmune condition * Have a diagnosed neurocognitive disorder * Have a skin condition that is likely to increase the risk of infection at the biopsy site * Frequent use of medication or recreational drugs likely to affect our results * Recent infection or vaccination * Known allergy to any vegetables * Participated in a nutrition supplementation study in the last month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflammation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inflammation

Contacts and locations

Locations

  • Public Health and Sports Sciences, University of Exeter

    Exeter, Devon, EX1 2LU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.